BioStorage Technologies has received a business license from the Chaoyang Commission of Commerce to provide its sample management services in Beijing, China. Through a partnership with Charles River Laboratories, BioStorage will provide technical consulting on sample management best practices. Charles River will host the physical storage of biological samples at its facility in Beijing. Both companies will focus on expanding sample management solutions to global biopharma companies interested in conducting research in China. The alliance aims to alleviate challenges associated with complex shipping regulations in exporting biological samples outside of the region.
 
“China represents an important opportunity for BioStorage Technologies as the region has experienced extreme growth in biopharmaceutical drug development in recent years,” said Greg Swanberg, chief executive officer, BioStorage Technologies. “We are honored to partner with an industry leader such as Charles River with the capabilities and infrastructure that allows us to bring technical expertise, world-class processes and technology platforms closer to the organizations conducting research in China.”
 
“Our partnership with BioStorage Technologies underscores our commitment to provide our global customers with best-in-class services throughout every facet of their early-stage drug development as well as clinical sample analysis and storage,” said Terrence Fisher, general manager, Charles River Laboratories. “Through this agreement, which leverages BioStorage Technologies’ proven sample storage platform, we can provide our clients in China with quick access to and increased visibility into sample inventory data, as well as unsurpassed storage processes for managing their research samples.”